HAGER INVESTMENT MANAGEMENT SERVICES, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2026645 NEW LONDON, NH

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,272,442

-$32,440 QoQ

Shares Held

5,089

+0.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HAGER INVESTMENT MANAGEMENT SERVICES, LLC holds $2,309,604 across 5 Biotechnology names. VRTX ranks #1 (98.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,089	$2,272,442
2	RLAY	Relay Therapeutics, Inc.	2,178	$21,671
3	PYXS	Pyxis Oncology, Inc.	5,000	$7,300
4	EXEL	Exelixis, Inc.	101	$4,331
5	ONC	BeOne Medicines Ltd.	13	$3,860

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,272,442	5,089	+0.1%	Shares	Sole	2026-05-12
2025-12-31	$2,304,882	5,084	-3.6%	Shares	Sole	2026-01-22
2025-09-30	$2,064,726	5,272	-1.4%	Shares	Sole	2025-11-12
2025-06-30	$2,379,594	5,345	-1.2%	Shares	Sole	2025-07-23
2025-03-31	$2,623,361	5,411	+0.5%	Shares	Sole	2025-05-02
2024-12-31	$2,168,136	5,384	—	Shares	Sole	2025-01-27
No filing history on record for this holder in this stock.